NO119798B - - Google Patents
Download PDFInfo
- Publication number
- NO119798B NO119798B NO156721A NO15672165A NO119798B NO 119798 B NO119798 B NO 119798B NO 156721 A NO156721 A NO 156721A NO 15672165 A NO15672165 A NO 15672165A NO 119798 B NO119798 B NO 119798B
- Authority
- NO
- Norway
- Prior art keywords
- compound
- acid
- nitro
- formula
- benzodiazepine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 14
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 2
- 229940053197 benzodiazepine derivative antiepileptics Drugs 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- -1 analgesic Substances 0.000 description 5
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- XIKCEAKJIODSMP-UHFFFAOYSA-N 2-(7-chloro-5-phenyl-2,3-dihydro-1,4-benzodiazepin-1-yl)-n,n-diethylethanamine Chemical compound C12=CC(Cl)=CC=C2N(CCN(CC)CC)CCN=C1C1=CC=CC=C1 XIKCEAKJIODSMP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- YNHGHPCGMBEGEU-UHFFFAOYSA-N 5-phenyl-1h-1,4-benzodiazepine Chemical compound C12=CC=CC=C2NC=CN=C1C1=CC=CC=C1 YNHGHPCGMBEGEU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Supply And Distribution Of Alternating Current (AREA)
- Plural Heterocyclic Compounds (AREA)
- Multicomponent Fibers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US343941A US3299053A (en) | 1964-02-11 | 1964-02-11 | Novel 1-and/or 4-substituted alkyl 5-aromatic-3h-1, 4-benzodiazepines and benzodiazepine-2-ones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO119798B true NO119798B (US20110009641A1-20110113-C00256.png) | 1970-07-06 |
Family
ID=23348328
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO156707A NO117367B (US20110009641A1-20110113-C00256.png) | 1964-02-11 | 1965-02-09 | |
| NO156721A NO119798B (US20110009641A1-20110113-C00256.png) | 1964-02-11 | 1965-02-10 | |
| NO156722A NO118273B (US20110009641A1-20110113-C00256.png) | 1964-02-11 | 1965-02-10 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO156707A NO117367B (US20110009641A1-20110113-C00256.png) | 1964-02-11 | 1965-02-09 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO156722A NO118273B (US20110009641A1-20110113-C00256.png) | 1964-02-11 | 1965-02-10 |
Country Status (13)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO120269B (US20110009641A1-20110113-C00256.png) * | 1965-11-02 | 1970-09-28 | Hoffmann La Roche | |
| US3464978A (en) * | 1967-04-21 | 1969-09-02 | Hoffmann La Roche | 1-substituted urea alkyl 1,2-dihydro-1,4-benzodiazepines and benzodiazepin - 2-ones |
| US3523939A (en) * | 1967-07-03 | 1970-08-11 | Hoffmann La Roche | 5-(2,6-disubstituted phenyl)-1,4-benzodiazepines and methods for their preparation |
| US3506403A (en) * | 1967-12-19 | 1970-04-14 | Hoffmann La Roche | Colorimetric method for determining iron in fluids |
| US3506404A (en) * | 1967-12-19 | 1970-04-14 | Hoffmann La Roche | Colorimetric method for determining iron in blood |
| US3609146A (en) * | 1968-11-01 | 1971-09-28 | Sandoz Ag | Substituted benzodiazepinone derivatives |
| DE2008612A1 (de) * | 1969-03-13 | 1970-10-01 | F. Hoffmann-La Roche & Co Ag, Basel (Schweiz) | Benzodiazepin-Derivate |
| US3691157A (en) * | 1970-08-12 | 1972-09-12 | Rodney Ian Fryer | Preparation of 7-substituted-1-(2-diethylaminoethyl)-5-(2-halophenyl)-1,3-dihydro-2h-1,4-benzodiazepin-2-ones |
| AT314541B (de) * | 1970-10-19 | 1974-04-10 | Sumitomo Chemical Co | Verfahren zur Herstellung von neuen Benzodiazepinen und ihren Salzen |
| US3678038A (en) * | 1971-04-01 | 1972-07-18 | Hoffmann La Roche | 1,4-benzodiazepin-5-ones and methods for the preparation thereof |
| US3856802A (en) * | 1971-05-10 | 1974-12-24 | Upjohn Co | 1,6-DISUBSTITUTED-4H-5-{8 4,3-a{9 BENZODIAZEPINES |
| US3872089A (en) * | 1971-05-14 | 1975-03-18 | Hoffmann La Roche | Substituted thienodiazepines |
| USRE31071E (en) * | 1971-12-09 | 1982-11-02 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler | 6-Aza-3H-1,4-benzodiazepines |
| US4008223A (en) * | 1971-12-09 | 1977-02-15 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler | 6-Aza-3H-1,4-benzodiazepines |
| US3859276A (en) * | 1972-12-13 | 1975-01-07 | Merck & Co Inc | 7-chloro-1,3-dihydro-5-2-polyfluoroalkoxyphenyl)-2h-1,4-benzodiazepin-2-ones |
| GB1414370A (en) * | 1973-08-24 | 1975-11-19 | Grindstedvaerket As | Benzodiazepines and their production |
| US4232016A (en) * | 1974-12-20 | 1980-11-04 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | 3-Fluorobenzodiazepines |
| US4246270A (en) * | 1976-05-26 | 1981-01-20 | E. I. Du Pont De Nemours And Company | 3-Fluorobenzodiazepines and compositions and uses thereof |
| DE2852606A1 (de) * | 1977-12-14 | 1979-06-21 | Gerot Pharmazeutika | 3-di-n-propyl-acetoxy-benzodiazepin-2-one und verfahren zu deren herstellung |
| AT361492B (de) * | 1978-12-18 | 1981-03-10 | Gerot Pharmazeutika | Verfahren zur herstellung von neuen 3-hydroxy- 1,4-benzodiazepin-2-onen |
| US8530463B2 (en) * | 2007-05-07 | 2013-09-10 | Hale Biopharma Ventures Llc | Multimodal particulate formulations |
| BRPI0811204A8 (pt) | 2007-05-10 | 2015-09-22 | Bristol Myers Squibb Co | Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina |
| DK2271347T3 (en) * | 2008-03-28 | 2016-08-15 | Hale Biopharma Ventures Llc | Administration of benzodiazepine compositions |
| PT3415139T (pt) | 2011-06-14 | 2022-06-20 | Neurelis Inc | Administração de benzodiazepina |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3121076A (en) * | 1964-02-11 | Benzodiazepinones and processes | ||
| US3109843A (en) * | 1963-11-05 | Process for preparing | ||
| US2461038A (en) * | 1947-05-15 | 1949-02-08 | Searle & Co | Chemical compositions and the preparation thereof |
| US2532292A (en) * | 1947-12-12 | 1950-12-05 | Searle & Co | Diarylmethyl ethers of amino alkanols |
| US2576106A (en) * | 1948-07-13 | 1951-11-27 | Searle & Co | N-dicyclohexyl, dialkylaminoalkanamides |
| US2687414A (en) * | 1948-11-26 | 1954-08-24 | Searle & Co | Method for producing aromatic aminoalkyl amines |
-
0
- GB GB1051795D patent/GB1051795A/en active Active
- GB GB1052144D patent/GB1052144A/en active Active
-
1964
- 1964-02-11 US US343941A patent/US3299053A/en not_active Expired - Lifetime
-
1965
- 1965-01-25 CH CH102465A patent/CH460030A/de unknown
- 1965-01-25 CH CH332768A patent/CH460793A/de unknown
- 1965-01-28 DE DE19651545933 patent/DE1545933A1/de active Pending
- 1965-01-28 CH CH118165A patent/CH467787A/de unknown
- 1965-01-28 CH CH118265A patent/CH458372A/de unknown
- 1965-01-29 IL IL22869A patent/IL22869A/en unknown
- 1965-01-30 DE DE19651545934 patent/DE1545934A1/de active Pending
- 1965-02-01 DE DE1545936A patent/DE1545936B2/de active Pending
- 1965-02-01 DE DE19651545935 patent/DE1545935A1/de active Pending
- 1965-02-02 FR FR4021A patent/FR4123M/fr not_active Expired
- 1965-02-03 IL IL22903A patent/IL22903A/xx unknown
- 1965-02-03 IL IL22902A patent/IL22902A/en unknown
- 1965-02-05 SE SE1507/65A patent/SE309597B/xx unknown
- 1965-02-05 SE SE1508/65A patent/SE307952B/xx unknown
- 1965-02-06 FR FR4639A patent/FR1455059A/fr not_active Expired
- 1965-02-08 GB GB5288/65A patent/GB1077358A/en not_active Expired
- 1965-02-08 GB GB5289/65A patent/GB1098242A/en not_active Expired
- 1965-02-08 IL IL22935A patent/IL22935A/xx unknown
- 1965-02-09 NO NO156707A patent/NO117367B/no unknown
- 1965-02-09 BE BE659444D patent/BE659444A/xx unknown
- 1965-02-09 BE BE659445D patent/BE659445A/xx unknown
- 1965-02-09 BE BE659442D patent/BE659442A/xx unknown
- 1965-02-09 DK DK65465AA patent/DK118249B/da unknown
- 1965-02-09 BE BE659443D patent/BE659443A/xx unknown
- 1965-02-09 NL NL6501578A patent/NL6501578A/xx unknown
- 1965-02-09 FR FR4800A patent/FR4138M/fr not_active Expired
- 1965-02-09 SE SE1617/65A patent/SE307953B/xx unknown
- 1965-02-09 FR FR4801A patent/FR1443116A/fr not_active Expired
- 1965-02-09 NL NL6501579A patent/NL6501579A/xx unknown
- 1965-02-10 ES ES0309168A patent/ES309168A1/es not_active Expired
- 1965-02-10 NL NL656501632A patent/NL141781B/xx unknown
- 1965-02-10 ES ES0309169A patent/ES309169A1/es not_active Expired
- 1965-02-10 BR BR167054/65A patent/BR6567054D0/pt unknown
- 1965-02-10 SE SE1688/65A patent/SE321477B/xx unknown
- 1965-02-10 BR BR167053/65A patent/BR6567053D0/pt unknown
- 1965-02-10 DK DK69265AA patent/DK105984C/da active
- 1965-02-10 NL NL6501631A patent/NL6501631A/xx unknown
- 1965-02-10 BR BR167051/65A patent/BR6567051D0/pt unknown
- 1965-02-10 BR BR167055/65A patent/BR6567055D0/pt unknown
- 1965-02-10 DK DK69165AA patent/DK107032C/da active
- 1965-02-10 NO NO156721A patent/NO119798B/no unknown
- 1965-02-10 ES ES0309170A patent/ES309170A1/es not_active Expired
- 1965-02-10 ES ES0309167A patent/ES309167A2/es not_active Expired
- 1965-02-10 NO NO156722A patent/NO118273B/no unknown
- 1965-04-06 FR FR12017A patent/FR4772M/fr not_active Expired
- 1965-04-07 FR FR12188A patent/FR4609M/fr not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO119798B (US20110009641A1-20110113-C00256.png) | ||
| Finnegan et al. | Preparation and isomerization of 5-alkylaminotetrazoles | |
| DK161968B (da) | Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf | |
| DE1620198A1 (de) | Heterozyklische Verbindungen | |
| DE2338669A1 (de) | Neue 4-aminochinazoline und verfahren zu ihrer herstellung | |
| NO174774B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner | |
| US3862171A (en) | 6-phenyl-4h-s-triazolo(1,5-a)(1,4)benzodiazepine-2-carboxylic acids and their esters | |
| Katritzky et al. | Kinetics and mechanisms of nucleophilic displacements with heterocycles as leaving groups. 2. N-benzylpyridinium cations: rate variation with steric effects in the leaving group | |
| Padwa et al. | Aziridine series. Reactions of trans-1, 3-dibenzoyl-2-phenylaziridine and related systems | |
| SU497776A3 (ru) | Способ получени производных диазепина | |
| CH517732A (de) | Verfahren zur Herstellung neuer Guanidin- Verbindungen | |
| RU2455289C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ 5,6-ДИГИДРО-7Н-ПИРРОЛО[1,2-d][1,4] БЕНЗОДИАЗЕПИН-6-ОНА | |
| Nagarajan et al. | Condensed heterotricycles: Pyrrolo [l, 2-α] quinoxaline derivatives | |
| Nagarajan et al. | Synthesis and reactions of 4, 6, 7, 8-tetrahydro-5 (1H)-cinnolinones | |
| IL24192A (en) | 1-phenylsulfonyl-2-benzimidazolinones and 1-phenylsulfonyl-2-benzimidazolinethiones and process for their preparation | |
| CH623314A5 (US20110009641A1-20110113-C00256.png) | ||
| DK156391B (da) | Analogifremgangsmaade til fremstilling af 3-aminopyrrolderivater | |
| NO153368B (no) | Fremgangsmaate til fremstilling av 10-okso-10,11-dihydro-5h-dibenz(b,f)-asepin-5-karboksamid | |
| SENDA et al. | Pyrimidine Derivatives and Related Compounds. XIX. Synthesis and Analgetic and Antiinflammatory Activities of 1, 3-Substituted 5-Dimethylaminouracil Derivatives | |
| Sasaki et al. | Synthesis and some conformational observations on the 3, 10-diazabicyclo [4.3. 1] decane system | |
| NO841084L (no) | 7,8,9,10-tetrahydrotieno (3,2-e) pyrido (4,3-b) indoler, fremgangsmaate til deres fremstilling, og legemidler som inneholder disse | |
| Fozard et al. | 530. Quinolizines. Part. VII. Rearrangement products from 1, 2, 3, 4-tetrahydro-1-hydroxyiminoquinolizinium bromides | |
| CH574426A5 (en) | Triazole carboxylates prepn - 1-(2-Benzoyl-phenyl)-1H-1, 2,4-triazole-3-carboxylates prepd. by reacting 2-aminobenzophenone diazo salts with dialkyl acylamino malonates | |
| DK158667B (da) | 5,6-dihydro-imidazooe1,5-aaaoe1,4aadiazepiner til anvendelse som mellemprodukter ved fremstillingen af farmakologisk aktive imidazooe1,5-aaaoe1,4aadiazepinforbindelser. | |
| DE2045378A1 (en) | Process for benzodiazepines and indole inte - rmediates |
